Annual report [Section 13 and 15(d), not S-K Item 405]

SHAREHOLDERS' EQUITY - Equity Compensation Plan Summary (Details)

v3.26.3
SHAREHOLDERS' EQUITY - Equity Compensation Plan Summary (Details) - 2014 and 2024 Equity Plan - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Aug. 31, 2026
Aug. 31, 2025
Aug. 31, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Outstanding, beginning of period (in shares) 489,500 524,500  
Granted (in shares) 30,000 0  
Exercised (in shares) (67,000) (35,000)  
Forfeited / expired (in shares) 0 0  
Outstanding, end of period (in shares) 452,500 489,500 524,500
Options exercisable (in shares) 422,500    
Outstanding, beginning of period (in dollars per share) $ 9.52 $ 9.42  
Granted (in dollars per share) 10.75 0  
Exercised (in dollars per share) 8.98 7.89  
Forfeited / expired (in dollars per share) 0 0  
Outstanding, end of period (in dollars per share) 9.69 $ 9.52 $ 9.42
Options exercisable (in dollars per share) $ 9.61    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term 3 years 3 months 18 days 3 years 9 months 18 days 4 years 8 months 12 days
Weighted average remaining contractual term, options exercisable 2 years 10 months 24 days    
Approximate aggregate intrinsic value, outstanding $ 813 $ 616 $ 877
Approximate aggregate intrinsic value, options exercisable $ 802